Shaping national networks to improve patient access to advanced therapy medicinal products in Europe
Publication date
2026-05
Authors
Hoek, Joyce M
Broeders, Mike
Hernandez, Juan Francisco
Main, Heather
Meij, Pauline
Warmerdam, Daniël O
Bloem, Lourens T.
ten Ham, R.M.T.
RSNN SIG Advanced Therapies Steering Committee
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
Advanced therapy medicinal products (ATMPs) offer the potential to address unmet medical needs, yet ensuring sustainable patient access remains challenging. In response, national ATMP networks are being established across Europe to strengthen ATMP development, cooperation between stakeholders and patient access. This targeted review provides an overview of (emerging) national ATMP networks across Europe and reflects on learnings and best practices. Drawing on insights from a Dutch multistakeholder workshop, a targeted European survey and interviews with established networks in the UK, Sweden and Ireland, this review concludes with recommendations to support the establishment of ATMP networks and improve patient access to ATMPs.
Keywords
Pharmacology, Drug Discovery
Citation
Hoek, J M, Broeders, M, Hernandez, J F, Main, H, Meij, P, Warmerdam, D O, Bloem, L T, Ten Ham, R M T & RSNN SIG Advanced Therapies Steering Committee 2026, 'Shaping national networks to improve patient access to advanced therapy medicinal products in Europe', Drug Discovery Today, vol. 31, no. 3, 104661. https://doi.org/10.1016/j.drudis.2026.104661